Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials
Human mesenchymal stem cells (MSCs) are multilineage somatic progenitor/stem cells that have been shown to possess immunomodulatory properties in recent years. Initially met with much skepticism, MSC immunomodulation has now been well reproduced across tissue sources and species to be clinically rel...
Main Authors: | Wang, Li-Tzu, Ting, Chiao-Hsuan, Yen, Men-Luh, Liu, Ko-Jiunn, Sytwu, Huey-Kang, Wu, Kenneth K., Yen, B. Linju |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095977/ |
Similar Items
-
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
by: Chen, Pei-Min, et al.
Published: (2011) -
Multipotent Human Mesenchymal Stromal Cells Mediate Expansion of Myeloid-Derived Suppressor Cells via Hepatocyte Growth Factor/c-Met and STAT3
by: Yen, B. Linju, et al.
Published: (2013) -
Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses
by: Wang, Wei-Bei, et al.
Published: (2015) -
Human pluripotent stem cell (PSC)-derived mesenchymal stem cells (MSCs) show potent neurogenic capacity which is enhanced with cytoskeletal rearrangement
by: Peng, Kai-Yen, et al.
Published: (2016) -
The developmental basis of mesenchymal stem/stromal cells (MSCs)
by: Sheng, Guojun
Published: (2015)